Glaxo Smith Kline reported audited consolidated and standalone earnings results for the year ended December 31, 2017. For the year, on consolidated basis, net profit was EGP 143,218,196 against loss of EGP 3,900,656 a year ago. For the year, on standalone basis, net profit was EGP 134,869,613 against loss of EGP 480,694 a year ago.